We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · December 15, 2016

Surgery vs 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma

Journal of Investigative Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Investigative Dermatology
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial
J Invest Dermatol 2016 Nov 23;[EPub Ahead of Print], HC Williams, F Bath-Hextall, M Ozolins, SJ Armstrong, GB Colver, W Perkins, PS Miller,

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading